Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia

References

• Chakraborty M, McGreal EP, Kotecha S. Acute lung injury in preterm newborn infants: mechanisms and management. Paediatr Respir Rev 2010;11:162–170.
   PubMed Web of Science ®Google Scholar
• Zoban P, Cerný M. Immature lung and acute lung injury. Physiol Res 2003;52:507–516.
   PubMed Web of Science ®Google Scholar
• Iliodromiti Z, Zygouris D, Sifakis S, Pappa KI, Tsikouras P, Salakos N, et al. Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. J Matern Fetal Neonatal Med 2013;26:1696–1704.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39–49.
   PubMedGoogle Scholar
• Joung KE, Kim HS, Lee J, Shim GH, Choi CW, Kim EK, et al. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia. Free Radic Res 2011;45:1024–1032.
   PubMed Web of Science ®Google Scholar
• Hadchouel A, Franco-Montoya ML, Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014;100:158–167.
   PubMed Web of Science ®Google Scholar
• Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in post surfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710–717.
   PubMed Web of Science ®Google Scholar
• Buczynski BW, Maduekwe ET, O’Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol 2013;37:69–78.
   PubMed Web of Science ®Google Scholar
• Viscardi RM. Perinatal inflammation and lung injury. Semin Fetal Neonatal Med 2012;17:30–35.
   PubMed Web of Science ®Google Scholar
• Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008;93: F455–F461.
   PubMed Web of Science ®Google Scholar
• Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev 2013;14:173–179.
   PubMed Web of Science ®Google Scholar
• Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog Lipid Res 1995;34:151–184.
   PubMed Web of Science ®Google Scholar
• Tigyi G, Parrill AL. Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res 2003;42:498–526.
   PubMed Web of Science ®Google Scholar
• Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004;26: 870–881.
   PubMed Web of Science ®Google Scholar
• Noguchi K, Herr D, Mutoh T, Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 2009;9: 15–23.
   PubMed Web of Science ®Google Scholar
• Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010;91:130–138.
   PubMed Web of Science ®Google Scholar
• Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 2010;50:157–186.
   PubMed Web of Science ®Google Scholar
• Teo ST, Yung YC, Herr DR, Chun J. Lysophosphatidic acid in vascular development and disease. IUBMB Life 2009; 61:791–799.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 2006;281:25822–25830.
   PubMed Web of Science ®Google Scholar
• van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradère JP, et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 2006;26: 5015–5022.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Natarajan V. Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling. Biochim Biophys Acta 2013;1831:86–92.
   PubMed Web of Science ®Google Scholar
• Racké K, Hammermann R, Juergens UR. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract. Pulm Pharmacol Ther 2000;13:99–114.
   PubMed Web of Science ®Google Scholar
• Georas SN, Berdyshev E, Hubbard W, Gorshkova IA, Usatyuk PV, Saatian B, et al. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy 2007;37:311–322.
   PubMed Web of Science ®Google Scholar
• Zhao J, He D, Su Y, Berdyshev E, Chun J, Natarajan V, Zhao Y. Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Am J Physiol Lung Cell Mol Physiol 2011;301:L547–L556.
   PubMed Web of Science ®Google Scholar
• Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008; 14:45–54.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tong J, He D, Pendyala S, Evgeny B, Chun J, et al. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir Res 2009;10:114.
   PubMed Web of Science ®Google Scholar
• Funke M, Zhao Z, Xu Y, Chun J, Tager AM. The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. Am J Respir Cell Mol Biol 2012;46: 355–364.
   PubMed Web of Science ®Google Scholar
• Qian Y, Hamilton M, Sidduri A, Gabriel S, Ren Y, Peng R, et al. Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts. J Med Chem 2012;55: 7920–7939.
   PubMed Web of Science ®Google Scholar
• Gan L, Xue JX, Li X, Liu DS, Ge Y, Ni PY, et al. Blockade of lysophosphatidic acid receptors LPAR1/3 ameliorates lung fibrosis induced by irradiation. Biochem Biophys Res Commun 2011;409:7–13.
   PubMed Web of Science ®Google Scholar
• Xue J, Gan L, Li X, Li J, Qi G, Wu Y, et al. Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis. Oncol Rep 2010;24: 1515–1520.
   PubMed Web of Science ®Google Scholar
• Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, et al. A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol 2010;160:1699–1713.
   PubMed Web of Science ®Google Scholar
• Kim EK, Lee KY, Lee HJ, Lee JA, Choi CW, Kim HS, et al. Heat shock pretreatment reduces intestinal injury in a neonatal rat model of early necrotizing enterocolitis. Neonatology 2013;103:1–6.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kang SW, Rhee SG, Clerch LB. Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia. Am J Physiol Lung Cell Mol Physiol 2001;280:L1212–L1217.
   PubMed Web of Science ®Google Scholar
• Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, et al. LPA3-mediated lysophosphatidic acid signaling in embryo implantation and spacing. Nature 2005;435: 104–108.
   PubMed Web of Science ®Google Scholar
• Yam J, Frank L, Roberts RJ. Age-related development of pulmonary antioxidant enzymes in the rat. Proc Soc Exp Biol Med 1978;157:293–296.
   PubMed Web of Science ®Google Scholar
• Frank L, Groseclose EE. Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984;18:240–244.
   PubMed Web of Science ®Google Scholar
• Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991;11: 463–494.
   PubMed Web of Science ®Google Scholar
• Tanswell AK, Freeman BA. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. I. Developmental profiles. Pediatr Res 1997;18:584–587.
   Web of Science ®Google Scholar
• Robles R, Palomino N, Robles A. Oxidative stress in the neonate. Early Hum Dev 2001;65:S75–S81.
   PubMed Web of Science ®Google Scholar
• Weinberger B, Laskin DL, Heck DE, Laskin JD. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol 2002;181:60–67.
   PubMed Web of Science ®Google Scholar
• Park MS, Rieger-Fackeldey E, Schanbacher BL, Cook AC, Bauer JA, Rogers LK, et al. Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. Pediatr Res 2007;62:652–657.
   PubMed Web of Science ®Google Scholar
• Rogers LK, Tipple TE, Nelin LD, Welty SE. Differential responses in the lungs of newborn mouse pups exposed to 85% or > 95% oxygen. Pediatr Res 2009;65:33–38.
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–1729.
   PubMedGoogle Scholar
• Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421–1431.
   PubMed Web of Science ®Google Scholar
• Ozer EA, Kumral A, Ozer E, Duman N, Yilmaz O, Ozkal S, Ozkan H. Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr Pulmonol 2005;39:35–40.
   PubMed Web of Science ®Google Scholar
• Ozer EA, Kumral A, Ozer E, Yilmaz O, Duman N, Ozkal S, et al. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res 2005;58:38–41.
   PubMed Web of Science ®Google Scholar